Analyst Consensus ?
ConsensusHold39 ratings
Bullish1538.4%
Neutral2359.0%
Bearish12.6%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Pfizer Inc. analyst ratings
Pfizer Inc. (PFE) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$29.79Current
$20Low
$39.14Average
$70High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Neutral | Maintain | Oct 9, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Oct 8, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Oct 6, 2026 |
| HSBC | Hold | Hold | Maintain | Sep 10, 2026 |
| Guggenheim | Buy | Buy | Maintain | Aug 7, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 13, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 10, 2026 |
| RBC Capital | Sector Perform | Underperform | Upgrade | Jun 10, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Apr 29, 2026 |
| UBS | Neutral | Neutral | Maintain | Apr 13, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 10, 2026 |
| Argus Research | Buy | Hold | Upgrade | Mar 2, 2026 |
| Freedom Broker | Buy | Buy | Maintain | Feb 9, 2026 |
| Goldman Sachs | Neutral | Buy | Downgrade | Apr 8, 2025 |
| Truist Securities | Buy | Buy | Maintain | Dec 18, 2024 |
| Daiwa Capital | Outperform | Neutral | Upgrade | Aug 8, 2024 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 31, 2024 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 31, 2024 |
| TD Cowen | Market Perform | Outperform | Downgrade | Jan 4, 2024 |
| Jefferies | Buy | Hold | Upgrade | Oct 16, 2023 |
| Credit Suisse | Neutral | Outperform | Downgrade | Jun 29, 2023 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Feb 1, 2023 |
| Atlantic Equities | Neutral | Neutral | Maintain | Feb 1, 2023 |
| Mizuho | Neutral | Neutral | Maintain | Dec 14, 2021 |
| DZ Bank | Buy | Hold | Upgrade | Feb 4, 2021 |
| Bernstein | Perform | Market Perform | Maintain | Nov 10, 2020 |
| Berenberg | Hold | Hold | Maintain | Sep 29, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Jul 30, 2019 |
| Argus | Outperform | Neutral | Upgrade | Jan 31, 2019 |
| Leerink Swann | Market Perform | Market Perform | Maintain | Jan 31, 2018 |
| Societe Generale | Hold | Hold | Maintain | Apr 6, 2016 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Feb 16, 2016 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Oct 20, 2015 |
| PiperJaffray | Overweight | Overweight | Maintain | Jun 17, 2015 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 28, 2015 |
| LBBW Research | Buy | Hold | Upgrade | Nov 14, 2013 |
| Standpoint Research | Sell | Hold | Downgrade | Jul 2, 2013 |
| Hilliard Lyons | Long Term Buy | Maintain | Jan 29, 2013 | |
| MKM Partners | Neutral | Buy | Downgrade | Nov 27, 2012 |
| ISI Group | Buy | Buy | Maintain | Apr 9, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $29.79. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Cantor Fitzgerald | Carter Gould | $28 | $28 | -6.0% | Oct 8, 2026 |
| Scotiabank | Analyst unavailable | $33 | $27.3 | +10.8% | Oct 6, 2026 |
| HSBC | Analyst unavailable | $30 | $27.78 | +0.7% | Sep 10, 2026 |
| Guggenheim | Analyst unavailable | $31 | $26.2 | +4.1% | Aug 7, 2026 |
| HSBC | Analyst unavailable | $28 | $24.32 | -6.0% | Jul 6, 2026 |
| UBS | Michael Yee | $27 | $26.34 | -9.4% | May 27, 2026 |
| Wolfe Research | Alexandria Hammond | $26 | $25.96 | -12.7% | May 14, 2026 |
| Morgan Stanley | Terence Flynn | $27 | $27.06 | -9.4% | Mar 17, 2026 |
| BMO Capital | Evan David Seigerman | $30 | $26.48 | +0.7% | Mar 9, 2026 |
| RBC Capital | Trung Huynh | $25 | $27.14 | -16.1% | Feb 24, 2026 |
| Barclays | Emily Field | $25 | $26.86 | -16.1% | Feb 19, 2026 |
| Daiwa | Narumi Nakagiri | $27 | $27.73 | -9.4% | Feb 12, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $27 | $25.88 | -9.4% | Jan 27, 2026 |
| UBS | Analyst unavailable | $25 | $25.43 | -16.1% | Jan 6, 2026 |
| Wolfe Research | Alexandria Hammond | $24 | $25.53 | -19.4% | Dec 17, 2025 |
| Morgan Stanley | Analyst unavailable | $28 | $25.89 | -6.0% | Dec 12, 2025 |
| HSBC | Rajesh Kumar | $29 | $25.33 | -2.7% | Dec 10, 2025 |
| Guggenheim | Analyst unavailable | $35 | $25.17 | +17.5% | Nov 24, 2025 |
| Goldman Sachs | Asad Haider | $26 | $24.22 | -12.7% | Nov 5, 2025 |
| Bernstein | Courtney Breen | $30 | $24.45 | +0.7% | Oct 31, 2025 |
| Morgan Stanley | Analyst unavailable | $32 | $25.24 | +7.4% | Oct 10, 2025 |
| UBS | Tim Anderson | $28 | $27.16 | -6.0% | Oct 1, 2025 |
| Cantor Fitzgerald | Carter Gould | $24 | $22.53 | -19.4% | Apr 22, 2025 |
| Truist Financial | Robyn Karnauskas | $32 | $25.89 | +7.4% | Dec 18, 2024 |
| Goldman Sachs | Chris Shibutani | $33 | $28.46 | +10.8% | Oct 30, 2024 |
| Bernstein | Courtney Breen | $32 | $29.67 | +7.4% | Oct 17, 2024 |
| Barclays | Carter Gould | $32 | $28.93 | +7.4% | Sep 25, 2024 |
| Daiwa | Narumi Nakagiri | $34 | $28.85 | +14.1% | Aug 7, 2024 |
| Wells Fargo | Mohit Bansal | $30 | $31.39 | +0.7% | Jul 31, 2024 |
| Goldman Sachs | Chris Shibutani | $34 | $31.39 | +14.1% | Jul 31, 2024 |
| Guggenheim | Vamil Divan | $36 | $30.72 | +20.8% | Jul 30, 2024 |
| Barclays | Carter Gould | $30 | $27.72 | +0.7% | Jul 10, 2024 |
| BMO Capital | Evan Seigerman | $36 | $29.6 | +20.8% | May 22, 2024 |
| Cantor Fitzgerald | Louise Chen | $45 | $26.97 | +51.1% | Feb 14, 2024 |
| Morgan Stanley | Thomas Yeh | $20 | $26.92 | -32.9% | Dec 14, 2023 |
| Morgan Stanley | Terence Flynn | $37 | $30.5 | +24.2% | Nov 27, 2023 |
| Morgan Stanley | Analyst unavailable | $45 | $43.84 | +51.1% | Feb 1, 2023 |
| Credit Suisse | Analyst unavailable | $50 | $43.59 | +67.8% | Feb 1, 2023 |
| Barclays | Analyst unavailable | $44 | $44.16 | +47.7% | Feb 1, 2023 |
| Atlantic Equities | Analyst unavailable | $46 | $44.16 | +54.4% | Feb 1, 2023 |
| Leerink Partners | Analyst unavailable | $48 | $44.16 | +61.1% | Feb 1, 2023 |
| Morgan Stanley | Analyst unavailable | $53 | $54.73 | +77.9% | Dec 14, 2022 |
| Goldman Sachs | Chris Shibutani | $60 | $53.37 | +101.4% | Dec 13, 2022 |
| Credit Suisse | Analyst unavailable | $55 | $48.33 | +84.6% | Nov 18, 2022 |
| Leerink Partners | David Risinger | $55 | $52.88 | +84.6% | May 23, 2022 |
| Wells Fargo | Mohit Bansal | $54.42 | $19.11 | +82.7% | May 10, 2022 |
| Wells Fargo | Mohit Bansal | $55 | $49.04 | +84.6% | May 9, 2022 |
| Morgan Stanley | Analyst unavailable | $52 | $49.68 | +74.6% | May 4, 2022 |
| Mizuho Securities | Vamil Divan | $55 | $49.07 | +84.6% | May 2, 2022 |
| Cantor Fitzgerald | Louise Chen | $75 | $53.12 | +151.8% | Apr 15, 2022 |
| Morgan Stanley | Terrance Flynn | $55 | $55.17 | +84.6% | Apr 10, 2022 |
| Citigroup | Andrew Baum | $57 | $55.17 | +91.3% | Apr 9, 2022 |
| Bank of America Securities | Geoff Meacham | $70 | $50.27 | +135.0% | Mar 12, 2022 |
| Barclays | Carter Gould | $54 | $51.7 | +81.3% | Feb 8, 2022 |
| Goldman Sachs | Chris Shibutani | $50 | $51.7 | +67.8% | Feb 8, 2022 |
| J.P. Morgan | Chris Schott | $57 | $51.7 | +91.3% | Feb 8, 2022 |
| BMO Capital | Evan Seigerman | $76 | $54.95 | +155.1% | Jan 15, 2022 |
| Bernstein | Aaron Gal | $65 | $56.22 | +118.2% | Jan 3, 2022 |
| Leerink Partners | Geoff Porges | $56 | $59.1 | +88.0% | Dec 22, 2021 |
| UBS | Colin Bristow | $60 | $54.78 | +101.4% | Dec 13, 2021 |
| Independent Research | Tobias Gottschalt | $54 | $49.8 | +81.3% | Nov 11, 2021 |
| Wolfe Research | Tim Anderson | $46 | $44.09 | +54.4% | Nov 3, 2021 |
| RBC Capital | Daniel Busby | $44 | $42.1 | +47.7% | Jul 29, 2021 |
| Argus Research | David Toung | $55 | $37.54 | +84.6% | Jun 1, 2021 |
Track every rating change on PFE the moment it posts. Free to start.
Start freeGet the PFE recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.